[HTML][HTML] Cannabis hyperemesis syndrome: an update on the pathophysiology and management

A Perisetti, M Gajendran, CS Dasari… - Annals of …, 2020 - ncbi.nlm.nih.gov
Cannabis hyperemesis syndrome (CHS) is a form of functional gut-brain axis disorder
characterized by bouts of episodic nausea and vomiting worsened by cannabis intake. It is …

Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature

G Burillo-Putze, JR Richards… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Cannabinoid hyperemesis syndrome (CHS) is an uncommon but unique
disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients …

Intravenous haloperidol versus ondansetron for cannabis hyperemesis syndrome (HaVOC): a randomized, controlled trial

AJ Ruberto, MLA Sivilotti, S Forrester, AK Hall… - Annals of Emergency …, 2021 - Elsevier
Study objective Little is known about the cause or optimal treatment of hyperemesis in
habitual cannabis users. Anecdotal evidence supports the use of haloperidol over traditional …

Changes in emergency department encounters for vomiting after cannabis legalization in Colorado

GS Wang, C Buttorff, A Wilks, D Schwam… - JAMA network …, 2021 - jamanetwork.com
Importance Cannabis hyperemesis syndrome is an emerging clinical issue associated with
cannabis use. Legalization of cannabis has led to an increase in vomiting-related illnesses …

A systematic review on cannabis hyperemesis syndrome and its management options

H Senderovich, P Patel, B Jimenez Lopez… - Medical Principles and …, 2022 - karger.com
Introduction: Several forms of cannabinoids are currently being used to manage nausea and
vomiting (N/V). Emerging cases of refractory N/V associated with chronic cannabis use …

Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department

S Wagner, J Hoppe, M Zuckerman, K Schwarz… - Clinical …, 2020 - Taylor & Francis
Introduction: Cannabinoid hyperemesis syndrome (CHS) is a disorder of cyclic and recurrent
nausea, vomiting, and abdominal pain associated with high-frequency and extended …

A pilot trial of topical capsaicin cream for treatment of cannabinoid hyperemesis syndrome

DJ Dean, N Sabagha, K Rose, A Weiss… - Academic …, 2020 - Wiley Online Library
Objectives Patients with cannabinoid hyperemesis syndrome (CHS) present frequently to
the emergency department. Previous case studies suggest dramatic symptomatic …

The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review

KM Takakuwa, RM Schears - International Journal of Emergency Medicine, 2021 - Springer
Background Cannabis is the most prevalent illegal drug used and the second most common
cause of ED drug-related complaints in the USA. Recently, newer more potent strains …

SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct …

M Sabbineni, W Scott, K Punia… - Academic …, 2024 - Wiley Online Library
Background Adults with cannabis hyperemesis syndrome (CHS) are increasingly presenting
to the emergency department (ED), and this systematic review will evaluate the direct …

Cannabis use patterns and association with hyperemesis: A comprehensive review

WL Hasler, O Alshaarawy… - Neurogastroenterology …, 2024 - Wiley Online Library
Background Cannabis use in the general population is prevalent and is rising because of
increased acceptance of its use, legalization in most US states, and perceived health …